Aptorum Group Collaborates With Covar Pharmaceuticals To Investigate At Least 3 Repurposed Drug Candidates (SACT-COV19) For Coronavirus Disease 2019 (COVID-19) Under Existing Smart-ACT™ Platform And Acticule Infectious Disease Platform
NEW YORK, March 31 (Bernama-BUSINESS WIRE) — Aptorum Group Limited (Nasdaq: APM) (“Aptorum Group”), a biopharmaceutical company focused on the development…